🇺🇸 FDA
Patent

US 11713922

Target residual moisture content for lyophilized drug product

granted A61KA61K9/19

Quick answer

US patent 11713922 (Target residual moisture content for lyophilized drug product) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K9/19